OR10K2 Inhibitors
OR10K2 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the OR10K2 receptor, a G protein-coupled receptor (GPCR) involved in olfactory signaling. The OR10K2 receptor belongs to the large olfactory receptor family, which is responsible for detecting odor molecules and initiating signaling cascades that lead to the perception of smell. These receptors, embedded in the olfactory epithelium, recognize specific odorants and transduce signals through intracellular pathways mediated by cyclic adenosine monophosphate (cAMP). Inhibitors of OR10K2 function by blocking the interaction between odorant molecules and the receptor, thereby preventing the activation of downstream signaling processes. The structure-activity relationship of these inhibitors is crucial in determining their affinity and selectivity for the OR10K2 receptor, with modifications in molecular scaffolds potentially enhancing inhibitory potency.
Chemically, OR10K2 inhibitors may be small organic molecules characterized by specific functional groups that allow for high-affinity binding to the receptor's active site. These inhibitors often contain structural features that mimic the natural ligands of OR10K2, which enhances their ability to bind competitively. However, their mode of action can vary, depending on whether they act as reversible or irreversible inhibitors. Reversible inhibitors typically form non-covalent interactions, while irreversible inhibitors might form covalent bonds with key residues in the receptor. The development of these inhibitors requires a deep understanding of the receptor's 3D structure and ligand-binding dynamics, which are often explored through computational modeling, crystallography, or nuclear magnetic resonance (NMR) techniques. The molecular interactions between OR10K2 and its inhibitors can also be studied through high-throughput screening, allowing for the identification of lead compounds with optimized binding properties.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can modulate olfactory receptor activity by binding to specific sites on the receptor protein or associated G-protein coupled receptor (GPCR) complex, leading to conformational changes that diminish the sensitivity and signaling of Olfactory receptor 10K2. | ||||||
Copper | 7440-50-8 | sc-211129 | 100 g | $51.00 | ||
Copper ions have been known to bind to olfactory receptors and modify their activity. In the case of Olfactory receptor 10K2, the binding of Cu2+ can alter receptor conformation and impair signal transduction, resulting in a diminished functional response to odorant molecules. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium Red is known to block calcium channels. Since the olfactory receptor signaling involves calcium-mediated pathways, the application of Ruthenium Red can indirectly inhibit the function of Olfactory receptor 10K2 by preventing calcium influx necessary for the receptor's activation and subsequent signal transduction. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
This is a synthetic analog of capsaicin and is a vanilloid receptor antagonist. While primarily affecting TRPV1 channels, it can also influence olfactory receptor function by modulating the ion channels and signaling pathways that are shared with Olfactory receptor 10K2, leading to decreased activation of the receptor. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein transport by inhibiting the ADP-ribosylation factor, which can indirectly inhibit Olfactory receptor 10K2 by impeding its proper trafficking to the cell surface where it can interact with odorants, thereby diminishing its functional activity. | ||||||
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $73.00 $163.00 | 15 | |
As a selective CB1 cannabinoid receptor inverse agonist, Rimonabant may also impact GPCR signaling pathways that are shared with olfactory receptors. Its action could lead to the altered function of downstream signaling components that are necessary for Olfactory receptor 10K2 activation, thus diminishing its functional activity. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is an antagonist of P2 purinergic receptors. It can indirectly inhibit the function of Olfactory receptor 10K2 by interfering with ATP-mediated signaling pathways, which are known to modulate olfactory receptor signaling, thereby leading to a decrease in receptor activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
As a glucose analog, 2-Deoxy-D-glucose interferes with glycolysis. Since olfactory receptor signaling requires ATP, an outcome of glycolysis, the inhibition of this metabolic pathway can diminish the functional activity of Olfactory receptor 10K2 by reducing the energy supply necessary for signal transduction. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid is an inhibitor of chloride channels, which can modulate GPCR activity, including olfactory receptors. By inhibiting chloride channels, niflumic acid can indirectly diminish the signaling of Olfactory receptor 10K2, as chloride ions play a role in the olfactory transduction process. | ||||||